Evidence map›Paper›PMID 25363895›Full record

ArticleLiver international : official journal of the International Association for the Study of the Liver2015

Fatigue in primary sclerosing cholangitis is associated with sympathetic over-activity and increased cardiac output.

Jessica K Dyson, Ahmed M Elsharkawy, Christopher A Lamb, Ahmad Al-Rifai, Julia L Newton, David E Jones, Mark Hudson

Open access · hybridAbstract read
In one paragraph

Article in Liver international : official journal of the International Association for the Study of the Liver, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Fatigue and Cognitive Impairment in Adults With Primary Sclerosing Cholangitis: Results From Concept Elicitation Interviews.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  5. Article
  6. Observational
  7. Primary sclerosing cholangitis.Nature reviews. Disease primers · 2025
    Review
  8. Current Therapeutics in Primary Sclerosing Cholangitis.Journal of clinical and translational hepatology · 2023
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Fatigue in primary sclerosing cholangitis is associated with sympathetic over-activity and increased cardiac output.Liver international : official journal of the International Association for the Study of the Liver · 2015
    Article
  14. Novel therapeutic targets in primary biliary cirrhosis.Nature reviews. Gastroenterology & hepatology · 2015
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Jessica K DysonThe Liver Unit, Freeman Hospital, Newcastle Upon Tyne, UK.
Ahmed M Elsharkawy
Christopher A Lamb
Ahmad Al-Rifai
Julia L Newton
David E Jones
Mark Hudson
Newcastle University · GBFreeman Hospital · GBNIHR Birmingham Liver Biomedical Research Unit · GBNIHR Newcastle Biomedical Research Centre · GBSalford Royal NHS Foundation Trust · GB

Funding

Medical Research Council G0500020Medical Research Council MC_PC_12039
6 · The paper itself

Abstract

BACKGROUND &

aimsPatients with primary sclerosing cholangitis (PSC) frequently highlight the impact of fatigue on their life quality. The study aims were to evaluate fatigue and its associations in PSC and investigate whether overt autonomic dysfunction contributes to the expression of fatigue.

methodsAll PSC patients under active follow-up at a regional liver centre were sent disease- and symptom-assessment tools. Three control groups were utilized; unselected community controls, patients with inflammatory bowel disease (IBD) without PSC, and cholestatic controls with primary biliary cirrhosis (PBC). A representative subgroup of PSC patients and normal controls underwent formal autonomic assessment.

resultsSymptom-assessment tools were returned by 40 non-transplanted patients. PSC patients had significantly worse fatigue than population controls (P = 0.005). Fatigue was significant compared to population controls whether or not patients had accompanying IBD, although was more marked in those with both PSC and IBD. In patients with PSC and IBD, fatigue severity and autonomic symptoms were significantly increased in those with prior significant surgical intervention. Clinically significant autonomic dysfunction was seen in 22.5% of PSC patients, and of those, 78% had significant fatigue. Neurally mediated hypotension was found in 60% of PSC patients compared to 8% in the control group. The PSC group had increased sympathetic activity and reduced parasympathetic activity.

conclusionFatigue is a significant problem in a minority of PSC patients and appears to be associated with autonomic dysfunction. Fatigued PSC patients should be screened for autonomic dysfunction and targeting such dysfunction represents a potential approach to treatment which warrants further exploration.

Indexed as

AdultAutonomic Nervous System DiseasesBrief Psychiatric Rating ScaleCardiac Output, HighCase-Control StudiesCholangitis, SclerosingFatigueFemaleFollow-Up StudiesHumansInflammatory Bowel DiseasesLiver Cirrhosis, BiliaryMaleMiddle AgedQuality of LifeSeverity of Illness Indexautonomic dysfunctionfatigueprimary sclerosing cholangitisquality of life

Identifiers

PMID25363895
PMCPMC4737110
OpenAlexW2009800094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.